Published in PLoS One on April 28, 2016
Aquaporins and Brain Tumors. Int J Mol Sci (2016) 0.76
A METHYLATION-TO-EXPRESSION FEATURE MODEL FOR GENERATING ACCURATE PROGNOSTIC RISK SCORES AND IDENTIFYING DISEASE TARGETS IN CLEAR CELL KIDNEY CANCER. Pac Symp Biocomput (2016) 0.75
In search of druggable targets for GBM amino acid metabolism. BMC Cancer (2017) 0.75
A Comparative Study of the Molecular Characteristics of Familial Gliomas and Other Cancers. Cancer Genomics Proteomics (2016) 0.75
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell (2006) 21.66
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) (2012) 20.08
The somatic genomic landscape of glioblastoma. Cell (2013) 11.73
Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62
Epidemiology and etiology of gliomas. Acta Neuropathol (2005) 6.14
SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics (2011) 5.62
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet (2009) 5.13
Long-term survival with glioblastoma multiforme. Brain (2007) 4.51
Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro Oncol (1999) 4.25
Mammalian nitric oxide synthases. Biochim Biophys Acta (1999) 3.55
Molecular subclassification of diffuse gliomas: seeing order in the chaos. Glia (2011) 2.32
MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer (2010) 1.74
Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat Biotechnol (2014) 1.71
Long-term survivors of glioblastoma: statistical aberration or important unrecognized molecular subtype? Cancer J (2003) 1.66
Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res (2002) 1.52
Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease. N Engl J Med (1989) 1.14
Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. Clin Cancer Res (2002) 1.14
IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival. Neuro Oncol (2013) 1.14
High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma. J Transl Med (2012) 1.11
Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir (Wien) (2009) 1.08
A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival. J Clin Neurosci (2011) 1.07
Molecular heterogeneity in glioblastoma: potential clinical implications. Front Oncol (2015) 1.06
Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA. Brief Bioinform (2014) 1.06
Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme. J Neurooncol (2000) 1.04
MiRNA expression patterns predict survival in glioblastoma. Radiat Oncol (2011) 1.01
Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis. Neuro Oncol (2015) 0.97
Network signatures of survival in glioblastoma multiforme. PLoS Comput Biol (2013) 0.96
Caveolin-1 regulates glioblastoma aggressiveness through the control of alpha(5)beta(1) integrin expression and modulates glioblastoma responsiveness to SJ749, an alpha(5)beta(1) integrin antagonist. Biochim Biophys Acta (2008) 0.94
Epigenetic Aging Signatures Are Coherently Modified in Cancer. PLoS Genet (2015) 0.92
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling. Int J Cancer (2014) 0.91
Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation. J Neurol (2000) 0.91
Outcome and prognostic factors in adult cerebellar glioblastoma. J Clin Neurosci (2013) 0.90
A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? Radiat Oncol (2014) 0.88
Transcriptional diversity of long-term glioblastoma survivors. Neuro Oncol (2014) 0.87
Genome-wide methylation analyses in glioblastoma multiforme. PLoS One (2014) 0.86
Long-term survival after malignant glioma. A clinical and histopathological study on the accuracy of the diagnosis in a population-based cancer register. Acta Oncol (1990) 0.84
An eQTL analysis of the human glioblastoma multiforme genome. Genomics (2014) 0.84
The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme. J Neurooncol (2014) 0.83
A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression. Epigenetics (2014) 0.82
Neurog1 and Neurog2 control two waves of neuronal differentiation in the piriform cortex. J Neurosci (2014) 0.82
DUSP28 contributes to human hepatocellular carcinoma via regulation of the p38 MAPK signaling. Int J Oncol (2014) 0.81
IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients. PLoS One (2015) 0.79
Rapid and convergent evolution in the glioblastoma multiforme genome. Genomics (2015) 0.77